MD
Insider
Mittie Doyle
Chief Medical OfficerMittie Doyle (Chief Medical Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Avalo Therapeutics, Inc. (AVTX). The largest single filing was $2.1M of AVTX (101,555 sh across 4 lots, as filed), executed May 6.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$2.5M
shares × price, as filed
Last traded
May 6
Filed May 7
Median ADV $28.3M across their filed names
Open performance→Volume by month
Buys $0
Sells $2.5M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
AVTXRecent filings
AVTXSALE
Avalo Therapeutics, Inc.
View filing →
$2.1M101,555 sh across 4 lots
Exec May 6
Filed May 7 · 5:30 PM ET AVTXSALE Avalo Therapeutics, Inc. View filing → $412K
25,492 sh × $16.15
Exec Mar 16
Filed Mar 18 · 5:30 PM ET